Co-Diagnostics, Inc. (CODX)
NASDAQ: CODX · Real-Time Price · USD
0.4937
-0.0763 (-13.39%)
At close: Oct 29, 2025, 4:00 PM EDT
0.4801
-0.0136 (-2.75%)
After-hours: Oct 29, 2025, 7:59 PM EDT
Co-Diagnostics Employees
Co-Diagnostics had 132 employees as of December 31, 2024. The number of employees decreased by 23 or -14.84% compared to the previous year.
Employees
132
Change (1Y)
-23
Growth (1Y)
-14.84%
Revenue / Employee
$7,603
Profits / Employee
-$272,659
Market Cap
23.77M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 132 | -23 | -14.84% |
| Dec 31, 2023 | 155 | 10 | 6.90% |
| Dec 31, 2022 | 145 | 44 | 43.56% |
| Dec 31, 2021 | 101 | 62 | 158.97% |
| Dec 31, 2020 | 39 | 14 | 56.00% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
CODX News
- 11 hours ago - Co-Diagnostics, Inc. Announces Closing of $7.0 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules - PRNewsWire
- 1 day ago - Co-Diagnostics, Inc. Announces Pricing of $7.0 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules - PRNewsWire
- 7 days ago - Co-Diagnostics Executive Leadership Team to Attend Global Health Exhibition 2025 in Riyadh, Saudi Arabia - PRNewsWire
- 13 days ago - Co-Diagnostics Announces Development of Proprietary Sample Prep Instrument for PoC Testing - PRNewsWire
- 16 days ago - Co-Diagnostics, Inc. to Attend 2025 Maxim Growth Summit - PRNewsWire
- 4 weeks ago - Co-Diagnostics, Inc. to Participate in the Lytham Partners Fall 2025 Investor Conference on September 30 - PRNewsWire
- 5 weeks ago - Co-Diagnostics, Inc. Announces Closing of $3.8 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules - PRNewsWire
- 6 weeks ago - Co-Diagnostics, Inc. Announces Pricing of $3.8 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules - PRNewsWire